The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia

A teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia was hospitalized and recovered in 15 days. The immunophenotyping analysis of peripheral blood cells was performed in two time points: the first was 1 month before (pre-infection) while the second was during COVID-19 pneumonia...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neuroimmunol
Päätekijät: Ciardi, Maria Rosa, Zingaropoli, Maria Antonella, Pasculli, Patrizia, Perri, Valentina, Tartaglia, Matteo, Valeri, Serena, Russo, Gianluca, Conte, Antonella, Mastroianni, Claudio Maria
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier B.V. 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361089/
https://ncbi.nlm.nih.gov/pubmed/32688146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2020.577323
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia